Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Shanghai Henlius Biotech, Inc. (2696.HK) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval ...
El País in English14h
Kerstin Noëlle Vokinger: ‘New cancer therapies are being approved for patient groups not included in clinical trials’
Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...
HealthDay on MSN19h
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, ...
HealthDay on MSN19h
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.